P270: Characterizing clinical actionability in the context of polygenic risk assessment*

• Bradford Powell,
• Adam Buchanan,
• Joanna Bulkley,
• Montserrat Garcia-Closas,
• Katrina Goddard,
• Stefan Massimino,
• Iftikhar Kullo,
• Jessica Hunter

Affiliations

Bradford Powell

University of North Carolina at Chapel Hill, Chapel Hill, NC

Adam Buchanan

Geisinger, Danville, PA

Joanna Bulkley

Kaiser Permanente Ctr. for Hlth. Res., Portland, OR

Montserrat Garcia-Closas

National Cancer Institute, Rockville, MD

Katrina Goddard

National Cancer Institute, Rockville, MD

Stefan Massimino

Kaiser Permanente Ctr. for Hlth. Res., Portland, OR

Iftikhar Kullo

Mayo Clinic, Rochester, MN

Jessica Hunter

RTI Intl., Durham, NC